Catalog detail · GLP-1 family
Retatrutide 20mg
Triple-agonist incretin receptor agonist. Orion Research Solutions supplies Retatrutide 20mg in standardized 20mg cartridge formats for cohort-level research use only.
Triple-agonist incretin receptor agonist
Mid-strength triple incretin-receptor agonist supplied for sustained metabolic cohorts.
- Quantity · 10–49USD / vial · $82
- Quantity · 50–99USD / vial · $77
- Quantity · 100+USD / vial · $74
Lyophilized powder · ambient-stable vial
Format · 20mg cartridge
- Synthesis method
- Solid-phase peptide synthesis (SPPS) of a triple incretin-receptor agonist, HPLC purification to ≥98%.
- Storage & handling
- Lyophilized powder, store at -20°C in a desiccated vial. Reconstitute with bacteriostatic water prior to research use.
- Sample COA
- Sample Certificate of Analysis
Research-use notice
Retatrutide 20mg listed on this page is labeled "For Research Use Only" and is not intended for human consumption. Orion Research Solutions supplies verified organizations operating in a research setting only.
Tier pricing
Wholesale pricing for Retatrutide 20mg is published per SKU across the 10-unit minimum. Final tier placement is returned on inquiry against intended end-use classification. Reach the wholesale desk at orion-research-solutions@polsia.app.